ACIU - AC Immune GAAP EPS of -$0.64 beats by $0.17 revenue of $14.8M beats by $3.37M
2024-03-14 07:12:31 ET
More on AC Immune
- AC Immune: Initial AD Findings Bring About Two Upcoming Catalysts
- Roche ends AC Immune partnership for Alzheimer’s drugs
- AC Immune issues updates on Phase 2 studies, cash runway
- Seeking Alpha’s Quant Rating on AC Immune
- Historical earnings data for AC Immune